Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
---|---|---|---|---|
|
|
Health: Unknown
Source: human faeces (Bilen2018e)
DNA G+C(%): 42.7
|
Mid T(℃): 37(+)
|
|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
---|---|---|---|---|
|
|
|
|
|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
---|---|---|---|---|
|
|
|
|
|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
---|---|---|---|---|
|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
---|---|---|---|---|
amp-sulb: Var(MIC50): 4, MIC90: 16, RNG: (0.25–32)
piper-taz: S(MIC50): 4, MIC90: 32, RNG: (1–64)
imipenem: S(MIC50): 0.5, MIC90: 2, RNG: (0.125–2)
|
|
|
|
moxifloxacin: Var(MIC50): 2, MIC90: >16, RNG: (0.25–>16)
|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
tigecycline: S(MIC50): 0.25, MIC90: 4, RNG: (0.125–4)
|
|
|
metronidazole: S(MIC50): 1, MIC90: 2, RNG: (0.25–2)
|
clindamycin: Var(MIC50): 1, MIC90: >32, RNG: (0.25–>32)
|